CAS: 4410-99-5; 2-Phenylethanethiol

上下游产品

CAS号6326-49-4 phenethylsulfan... | CAS号34372-24-2 phenethylsulfan... | CAS号4808-30-4 双(三正丁基锡)硫化物 | CAS号103-63-9 β-溴苯乙烷 | CAS号100-39-0 溴化苄 | CAS号51380-98-4 2-phenethylsulf... | CAS号109-72-8 正丁基锂 | CAS号3278-36-2 ethoxy-phenethy... | CAS号4025-71-2 2-苯基-乙烷磺酰氯 | CAS号27846-23-7 1-methyl-4-(2-p... | CAS号932-22-9 4,5-二氯哒嗪-3(2H)-酮 | CAS号5654-72-8 2-phenylethyl t... | CAS号29910-92-7 3-(4-methoxyphe... | CAS号34372-24-2 phenethylsulfan... | CAS号62536-81-6 3-(2,4-dimethox... | CAS号54894-37-0 [(2-phenylethox... | CAS号103-81-1 2-苯乙酰胺 | CAS号13329-15-2 3,4-dihydro-1H-...

苯乙烯置于硫化氢体系中,用 环己烷 作为反应溶剂,化学反应 1.0H,以85%的收率获得产物2-苯乙硫醇
参考文献:一种硫醇化合物的制备方法
标题:一种硫醇化合物的制备方法
摘要:本发明提供了一种硫醇化合物的制备方法,即:在温度为20oc‑80°C,压力为0.10‑0.12Mpa的条件下,硫化氢与含有碳碳双键的有机化合物在固体碱催化剂和反应溶剂中经michael加成进行气液相反应制备硫醇化合物的方法.所述制备方法反应条件温和;所采用的固体碱催化剂碱性强,碱性催化位具有较大位阻作用,适用性广;固体碱催化剂容易过滤回收,经活化后可重复使用;反应转化率和选择性高,减少副反应的发生,反应的原子经济利用率高.

专利信息

专利号:US-8293930-B1
优先权日:2004-06-25
标题 :One pot synthesis of taxane derivatives and their conversion to paclitaxel and docetaxel
发明人：NAIDU RAGINA
权利人:NAIDU RAGINA; CHATHAM BIOTEC LTD
摘要:A process is provided for the semi-synthesis of taxane intermediates useful in the preparation of paclitaxel and docetaxel, in particular, the semi-synthesis of protected taxane intermediate in a one pot reaction of protecting the C-7 and C-10 positions and attaching a side chain at the C-13 position and subsequently deprotecting the group to form paclitaxel or docetaxel, and taxane intermediates.

专利号:US-7893283-B2
优先权日:2004-06-04
标题:Semi-synthesis of taxane intermediates and their conversion to paclitaxel and docetaxel
发明人：NAIDU RAGINA
权利人:CHATHAM BIOTEC LTD
摘要:A process is provided for the semi-synthesis of taxane intermediates useful in the preparation of paclitaxel and docetaxel, in particular, the semi-synthesis of protected taxane intermediates.

专利号:WO-2008032104-A1
优先权日:2006-09-15
标题:One pot synthesis of taxane derivatives and their conversion to paclitaxel and docetaxel
发明人：WALKER ROSS THOMSON; NAIDU RAGINA
权利人:CHATHAM BIOTEC LTD; WALKER ROSS THOMSON; NAIDU RAGINA
摘要:A process is provided for the semi-synthesis of taxane intermediates useful in the preparation of paclitaxel and docetaxel, in particular, the semi-synthesis of protected taxane intermediate in a one pot reaction, of protecting the C-10 and attaching a side chain at C-13 position and subsequently deprotecting the group to form paclitaxel or docetaxel, and intermediates used therein.

专利号:US-7202370-B2
优先权日:2003-10-27
标 题 :Semi-synthesis of taxane intermediates from 9-dihydro-13-acetylbaccatin III
发明人：NAIDU RAGINA
权利人:CONOR MEDSYSTEMS INC
摘要:A method is provided for the semi-synthesis of taxane intermediates useful in the preparation of paclitaxel and docetaxel from 9-dihydro-13-acetylbaccatin III. The preparation of a suitably protected baccatin III backbone from 9-dihydro-13-acetylbaccatin III, and the insertion of the phenylisoserine side chain onto the protected baccatin III from 9-dihydro-13-acetylbaccatin III to form the taxane derivatives, paclitaxel and docetaxel is disclosed.

专利号:US-8618281-B2
优先权日:2006-01-03
标 题 :Geometric synthesis of porphyrin rods
发明人：LINDSEY JONATHAN S; YU LIANHE; THAMYONGKIT PATCHANITA; BHISE ANIL D
权利人:LINDSEY JONATHAN S; YU LIANHE; THAMYONGKIT PATCHANITA; BHISE ANIL D; UNIV NORTH CAROLINA STATE
摘要:A method of making a compound of Formula I′ n ncomprises reacting a compound of the formula DLCHO, with a compound of the formulan n nto produce the compound of Formula I′. Methods of using the compounds are also described, particularly as intermediates for the synthesis of porphyrin rods, which porphyrin rods are in turn useful for (among other things) the production of molecular memory devices.

专利号:US-10919904-B2
优先权日:2016-08-17
标 题 :Northern-southern route to synthesis of bacteriochlorins
发明人：LIU YIZHOU; LINDSEY JONATHAN S; ALLU SRINIVASA RAO; FUJITA HIKARU
权利人:UNIV NORTH CAROLINA STATE
摘要:Described herein are chlorins, bacteriochlorins, methods and intermediates for the synthesis of bacteriochlorins, and methods of using such bacteriochlorins for, among other things, diagnostic and therapeutic purposes such as luminescent compounds in flow cytometry, and as active agents in photodynamic therapy (PDT).